Pneumococcus (Streptococcus pneumoniae) can cause a range of illnesses. In mild cases, it may lead to sinusitis or ear infections, but it can also result in serious and potentially life‐threatening conditions such as pneumonia, sepsis, and meningitis. Transmission occurs mainly through droplets (coughing or sneezing), close contact with infected individuals, or touching contaminated surfaces.
Pneumococcal Vaccines stimulate the immune system to produce antibodies against multiple serotypes, helping to prevent pneumonia and invasive infections. Infants and older adults are at greater risk of severe disease and complications, making vaccination one of the effective way to reduce infection and its serious consequences.
Who Should Receive Pneumococcal Vaccines?
Who Is Considered High‐risk?
15‐valent Conjugate Vaccine (Vaxneuvance) | 20‐valent Conjugate Vaccine (Prevnar 20) | 23‐valent Polysaccharide Vaccine (Pneumovax 23) | |
|---|---|---|---|
| Serotypes covered | 1、3、4、5、6A、6B、7F、9V、14、18C、19A、19F、22F、23F、33F | 1、3、4、5、6A、6B、7F、8、9V、10A、11A、12F、14、15B、18C、19A、19F、22F、23F、33F | 1、2、3、4、5、6B、7F、8、9N、9V、10A、11A、12F、14、15B、17F、18C、19A、19F、20、22F、23F、33F |
| Target groups |
|
|
|
| Dosage |
|
|
|
Prior to receiving any pneumococcal vaccine, a medical assessment should be conducted to determine the most appropriate option. For further information, please consult our staff at the time of booking.
If you have any enquiries about our packages, please feel free to contact our healthcare team through the channel listed below for more details about the service.